Sho Ohta

826 total citations
31 papers, 531 citations indexed

About

Sho Ohta is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sho Ohta has authored 31 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Sho Ohta's work include Pluripotent Stem Cells Research (7 papers), Epigenetics and DNA Methylation (4 papers) and CRISPR and Genetic Engineering (4 papers). Sho Ohta is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), Epigenetics and DNA Methylation (4 papers) and CRISPR and Genetic Engineering (4 papers). Sho Ohta collaborates with scholars based in Japan, United States and Australia. Sho Ohta's co-authors include Takuya Yamamoto, Alexander Hoffmann, Quen J. Cheng, Roberto Spreafico, Katherine M. Sheu, Yasuhiro Yamada, Adewunmi Adelaja, Brooks Taylor, Eisuke Nishida and Tomoyo Ukai and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sho Ohta

30 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sho Ohta Japan 12 307 143 73 62 55 31 531
Lauren A. Solomon Canada 14 260 0.8× 121 0.8× 59 0.8× 65 1.0× 62 1.1× 22 483
Chengyu Prince United States 11 333 1.1× 89 0.6× 55 0.8× 43 0.7× 78 1.4× 20 540
Anna Abramowicz Poland 6 440 1.4× 103 0.7× 36 0.5× 149 2.4× 52 0.9× 8 636
Walter Pouwels Netherlands 12 333 1.1× 250 1.7× 77 1.1× 23 0.4× 78 1.4× 16 610
Natasa Zamurovic Switzerland 9 365 1.2× 74 0.5× 60 0.8× 60 1.0× 90 1.6× 16 546
Antonella Romano Italy 10 305 1.0× 243 1.7× 105 1.4× 71 1.1× 72 1.3× 19 602
Violetta Steeples United Kingdom 11 347 1.1× 99 0.7× 50 0.7× 29 0.5× 33 0.6× 16 588
Prameladevi Chinnasamy United States 12 130 0.4× 170 1.2× 36 0.5× 45 0.7× 44 0.8× 14 388
Michele Pelosi Italy 12 325 1.1× 312 2.2× 73 1.0× 25 0.4× 89 1.6× 16 717
Junfeng Wu China 14 252 0.8× 190 1.3× 62 0.8× 68 1.1× 149 2.7× 26 547

Countries citing papers authored by Sho Ohta

Since Specialization
Citations

This map shows the geographic impact of Sho Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Ohta more than expected).

Fields of papers citing papers by Sho Ohta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Ohta. The network helps show where Sho Ohta may publish in the future.

Co-authorship network of co-authors of Sho Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Ohta. A scholar is included among the top collaborators of Sho Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Ohta. Sho Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Yosuke, et al.. (2024). A versatile in vivo platform for reversible control of transgene expression in adult tissues. Stem Cell Reports. 20(1). 102373–102373.
2.
Ohta, Sho & Yasuhiro Yamada. (2023). Exploring the potential of in vivo reprogramming for studying embryonic development, tissue regeneration, and organismal aging. Current Opinion in Genetics & Development. 81. 102067–102067. 3 indexed citations
3.
Ito, Kenji, Kohei Nagata, Sho Ohta, et al.. (2022). The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. Cell Reports. 39(4). 110721–110721. 10 indexed citations
4.
Tsunekawa, Shin, Mio Kabata, Sho Ohta, et al.. (2022). MYCL-mediated reprogramming expands pancreatic insulin-producing cells. Nature Metabolism. 4(2). 254–268. 10 indexed citations
5.
Shibata, Hirofumi, Mio Kabata, Masaki Kato, et al.. (2021). DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency. Nature Communications. 12(1). 5041–5041. 25 indexed citations
6.
Yagi, Masaki, Mio Kabata, Akito Tanaka, et al.. (2020). Identification of distinct loci for de novo DNA methylation by DNMT3A and DNMT3B during mammalian development. Nature Communications. 11(1). 3199–3199. 58 indexed citations
7.
Arakawa, Yoshiki, Yosuke Yamada, Tomoyo Ukai, et al.. (2019). Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor. Cell Reports. 26(10). 2608–2621.e6. 33 indexed citations
8.
Roy, Koushik, Simon Mitchell, Yi Liu, et al.. (2019). A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation. Immunity. 50(3). 616–628.e6. 53 indexed citations
9.
Cheng, Quen J., Supriya Sen, Sho Ohta, et al.. (2019). Sequential conditioning-stimulation reveals distinct gene- and stimulus-specific effects of Type I and II IFN on human macrophage functions. Scientific Reports. 9(1). 5288–5288. 26 indexed citations
10.
Yagi, Masaki, Mio Kabata, Tomoyo Ukai, et al.. (2019). De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency. Stem Cell Reports. 12(5). 1113–1128. 24 indexed citations
11.
Ohta, Sho, Masaki Yagi, Akito Tanaka, et al.. (2019). Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells. Biochemical and Biophysical Research Communications. 519(4). 705–713. 5 indexed citations
12.
Lee, Joon-Seong, et al.. (2015). Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State. Journal of Biological Chemistry. 290(52). 31173–31188. 11 indexed citations
13.
Ohta, Sho, Eisuke Nishida, Shinya Yamanaka, & Takuya Yamamoto. (2013). Global Splicing Pattern Reversion during Somatic Cell Reprogramming. Cell Reports. 5(2). 357–366. 47 indexed citations
14.
Takiguchi, Yuichi, Katsushi Kurosu, Osamu Okada, et al.. (2008). Impaired spermatogenesis by testicular sarcoidosis. Respirology. 13(7). 1082–1084. 4 indexed citations
15.
Ohta, Sho, et al.. (2006). Development of an Automatic Alarm System for the Elderly Living Alone. Medical Informatics. 26(1). 1–11. 2 indexed citations
16.
Furuya, Y., Sho Ohta, N Sato, T Kotake, & Motoyuki Masai. (2002). Comparison of T1c versus T2 prostate cancers in Japanese patients undergoing radical prostatectomy. International Urology and Nephrology. 33(1). 73–76. 4 indexed citations
17.
Furuya, Yuzo, Sho Ohta, N Sato, T Kotake, & Motoyuki Masai. (2001). Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia. International Urology and Nephrology. 33(4). 645–648. 2 indexed citations
18.
Nihei, Naoki, Sho Ohta, Hiroyuki Kugoh, et al.. (1999). Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7. Genes Chromosomes and Cancer. 24(1). 1–8. 24 indexed citations
19.
Nambu, Mitsuhiko, et al.. (1999). A case of juvenile myelomonocytic leukemia with ocular infiltration. Annals of Hematology. 78(12). 568–570. 2 indexed citations
20.
Nakano, Kyoko, Takashi Sakamoto, Sho Ohta, et al.. (1993). An Unspliced cDNA for Human Dihydrolipoamide Succinyltransferase: Characterization and Mapping of the Gene to Chromosome 14q24.2-q24.3. Biochemical and Biophysical Research Communications. 196(2). 527–533. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026